For the year ending 2025-12-31, INDV made $1,239M in revenue. $210M in net income. Net profit margin of 16.95%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net revenue | 1,239 | |||
| Cost of sales | 246 | |||
| Gross profit | 994 | |||
| Selling, general and administrative | 634 | |||
| Research and development | 97 | |||
| Acquired in-process research and development | 0 | |||
| Litigation settlement | -3 | |||
| Other operating (income) expense, net | -3 | |||
| Operating income (loss) | 262 | |||
| Interest income | 22 | |||
| Interest expense | 45 | |||
| Income (loss) before income taxes | 239 | |||
| Income tax expense (benefit) | 29 | |||
| Net income (loss) | 210 | |||
| Basic EPS | 1.68 | |||
| Diluted EPS | 1.64 | |||
| Basic Average Shares | 125,000,000 | |||
| Diluted Average Shares | 128,000,000 | |||
Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV)